BACKGROUND: The importance of human herpesvirus 6 (HHV-6) as a pathogen in febrile infants </=90 days of age is unknown. OBJECTIVE: To determine whether febrile infants 90 days of age and younger evaluated for sepsis have evidence of HHV-6 DNA in plasma or cerebrospinal fluid (CSF). METHODS: Febrile infants </=90 days of age were tested for HHV-6 DNA using a real time quantitative fluorescent probe polymerase chain reaction assay. RESULTS: Eighty samples from 47 infants were tested for HHV-6 DNA; 5 of 47 infants (10.6%) had HHV-6 DNA in plasma. In 2 of the 5 infants with HHV-6 DNA in plasma, HHV-6 DNA was also detected in the CSF. Both infants with evidence of HHV-6 DNA in plasma and CSF had HHV-6 Variant A infection. The quantity of HHV-6 DNA detected ranged from 70 to 169,000 DNA copies/ml. One infant with HHV-6 variant B infection had concomitant Escherichia coli bacteremia and urinary tract infection. CONCLUSIONS: Approximately 10% of febrile infants </=90 days of age evaluated for sepsis had evidence of HHV-6 infection. HHV-6 Variant A and B infections were seen in these young infants. HHV-6 DNA was found in infants with and without another explanation for fever. Quantification of viral DNA may be important in determining the relevance of HHV-6 DNA in clinical specimens.
BACKGROUND: The importance of human herpesvirus 6 (HHV-6) as a pathogen in febrile infants </=90 days of age is unknown. OBJECTIVE: To determine whether febrile infants 90 days of age and younger evaluated for sepsis have evidence of HHV-6 DNA in plasma or cerebrospinal fluid (CSF). METHODS: Febrile infants </=90 days of age were tested for HHV-6 DNA using a real time quantitative fluorescent probe polymerase chain reaction assay. RESULTS: Eighty samples from 47 infants were tested for HHV-6 DNA; 5 of 47 infants (10.6%) had HHV-6 DNA in plasma. In 2 of the 5 infants with HHV-6 DNA in plasma, HHV-6 DNA was also detected in the CSF. Both infants with evidence of HHV-6 DNA in plasma and CSF had HHV-6 Variant A infection. The quantity of HHV-6 DNA detected ranged from 70 to 169,000 DNA copies/ml. One infant with HHV-6 variant B infection had concomitant Escherichia coli bacteremia and urinary tract infection. CONCLUSIONS: Approximately 10% of febrile infants </=90 days of age evaluated for sepsis had evidence of HHV-6 infection. HHV-6 Variant A and B infections were seen in these young infants. HHV-6 DNA was found in infants with and without another explanation for fever. Quantification of viral DNA may be important in determining the relevance of HHV-6 DNA in clinical specimens.
Authors: A C Rentz; J Stevenson; W Hymas; D Hillyard; G J Stoddard; E W Taggart; C L Byington Journal: Eur J Clin Microbiol Infect Dis Date: 2007-03-16 Impact factor: 3.267
Authors: William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson Journal: Epilepsia Date: 2008-07-08 Impact factor: 5.864
Authors: Mark A Poritz; Anne J Blaschke; Carrie L Byington; Lindsay Meyers; Kody Nilsson; David E Jones; Stephanie A Thatcher; Thomas Robbins; Beth Lingenfelter; Elizabeth Amiott; Amy Herbener; Judy Daly; Steven F Dobrowolski; David H-F Teng; Kirk M Ririe Journal: PLoS One Date: 2011-10-19 Impact factor: 3.240
Authors: Anne J Blaschke; Kristen M Holmberg; Judy A Daly; Amy L Leber; Jennifer Dien Bard; Ernest K Korgenski; Kevin M Bourzac; Kristen J Kanack Journal: J Clin Microbiol Date: 2018-06-25 Impact factor: 5.948
Authors: Adekunle G Fakunle; Babatunde Olusola; Nkosana Jafta; Adedayo Faneye; Dick Heederik; Lidwien A M Smit; Rajen N Naidoo Journal: Int J Environ Res Public Health Date: 2020-03-13 Impact factor: 3.390